Literature DB >> 18787972

Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy.

Potic B Milan1, Ignjatovic M Ivan.   

Abstract

The objective is to evaluate resistance between community-acquired urinary tract infections (CAUTI), nosocomialy-acquired urinary tract infections (NAUTI), and empirical therapy adequacy. E. coli is the predominant pathogen of both CAUTI and NAUTI, followed by Klebsiella spp. in NAUTI and Pseudomonas spp. in catheter-associated urinary tract infections. The highest level of general resistance was found among isolates of NAUTI and catheter-associated UTI followed by CAUTI isolates. Absolute or high level resistance for commonly used empirical antimicrobial therapy was found in catheter-associated UTI and NAUTI while resistance among CAUTI was respectable. Patients with NAUTI as well as patients with catheter-associated urinary tract infections have similar resistance and similar microorganisms isolated as a causative agents, and should not be empirically treated unless the clinical emergency requests.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787972     DOI: 10.1007/s11255-008-9468-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  21 in total

Review 1.  Treatment of bacterial urinary tract infections: presence and future.

Authors:  Florian M E Wagenlehner; Kurt G Naber
Journal:  Eur Urol       Date:  2006-01-18       Impact factor: 20.096

2.  Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.

Authors:  S J Drews; S M Poutanen; T Mazzulli; A J McGeer; A Sarabia; S Pong-Porter; Y Rzayev; B Willey; K Green; D E Low
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Determinants of long-term survival after major surgery and the adverse effect of postoperative complications.

Authors:  Shukri F Khuri; William G Henderson; Ralph G DePalma; Cecilia Mosca; Nancy A Healey; Dharam J Kumbhani
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

Review 4.  Urinary-catheter-associated infections in the elderly.

Authors:  Calvin M Kunin
Journal:  Int J Antimicrob Agents       Date:  2006-07-10       Impact factor: 5.283

5.  Active surveillance of nosocomial infections in urologic patients.

Authors:  Antonella Agodi; Martina Barchitta; Agata Anzaldi; Francesco Marchese; Astrid Bonaccorsi; Mario Motta
Journal:  Eur Urol       Date:  2006-06-06       Impact factor: 20.096

Review 6.  Urinary tract infections in the frail elderly: issues for diagnosis, treatment and prevention.

Authors:  Chesley L Richards
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.

Authors:  M Olafsson; K G Kristinsson; J A Sigurdsson
Journal:  Scand J Prim Health Care       Date:  2000-03       Impact factor: 2.581

8.  Bacterial colonization of double J stents and bacteriuria frequency.

Authors:  Cem Ozden Yeniyol; Abidin Tuna; Hasan Yener; Nuri Zeyrek; Atilla Tilki; Ayten Coskuner
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections.

Authors:  Joshua P Metlay; Brian L Strom; David A Asch
Journal:  J Antimicrob Chemother       Date:  2003-02-25       Impact factor: 5.790

10.  Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent.

Authors:  Ali Ferruh Akay; Uğur Aflay; Abdullah Gedik; Hayrettin Sahin; Mehmet Kamuran Bircan
Journal:  Int Urol Nephrol       Date:  2006-12-14       Impact factor: 2.266

View more
  7 in total

1.  The clinical rate of antibiotic change following empiric treatment for suspected urinary tract infections.

Authors:  Jonathan Dokter; Lauren E Tennyson; Laura Nguyen; Esther Han; Larry T Sirls
Journal:  Int Urol Nephrol       Date:  2019-11-05       Impact factor: 2.370

2.  Risk factors for hospital-acquired urinary tract infection: a case-control study.

Authors:  Ljiljana Markovic-Denic; Biljana Mijovic; Slavenka Jankovic
Journal:  Int Urol Nephrol       Date:  2010-09-17       Impact factor: 2.370

3.  Profiles of the bacterial community in short-term indwelling urinary catheters by duration of catheterization and subsequent urinary tract infection.

Authors:  Jyothi Manohar; Savannah Hatt; Brigette B DeMarzo; Freida Blostein; Anna E W Cronenwett; Jianfeng Wu; Kyu Han Lee; Betsy Foxman
Journal:  Am J Infect Control       Date:  2019-09-17       Impact factor: 2.918

4.  A Tool to Assess the Signs and Symptoms of Catheter-Associated Urinary Tract Infection: Development and Reliability.

Authors:  Tom J Blodgett; Sue E Gardner; Nicole P Blodgett; Lisa V Peterson; Melissa Pietraszak
Journal:  Clin Nurs Res       Date:  2014-09-22       Impact factor: 2.075

5.  Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization.

Authors:  Catherine S Forster; Joshua Courter; Elizabeth C Jackson; Joel E Mortensen; David B Haslam
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

6.  Bacteriuria and asymptomatic infection in chronic patients with indwelling urinary catheter: The incidence of ESBL bacteria.

Authors:  Sorin Albu; Septimiu Voidazan; Doina Bilca; Monica Badiu; Andreea Truţă; Marian Ciorea; Alin Ichim; Diana Luca; Geanina Moldovan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

7.  The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide.

Authors:  Charlotte Sahlberg Bang; Annica Kinnunen; Marie Karlsson; Anna Önnberg; Bo Söderquist; Katarina Persson
Journal:  BMC Microbiol       Date:  2014-03-14       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.